Thursday - January 29, 2026

TRYPTYR by Aerie Pharmaceuticals expected to drive market size of Dry Eye Disease

Explore DelveInsight’s comprehensive report on TRYPTYR (Aerie Pharmaceuticals), offering market insights, sales forecasts, and analysis of the drug landscape through 2034.   [Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on … Continue reading

Government Agencies and Enterprise Organizations Gain Streamlined Access to Mission-Ready Drone Systems Through Outland Secure

The gap between consumer drone retail and institutional procurement requirements creates real obstacles for agencies and enterprises trying to deploy aerial technology. We built Outland Secure specifically to bridge that gap with a procurement model that speaks the language of … Continue reading

Donanemab by Eli Lilly and Company expected to drive market size of Alzheimer’s Disease

Explore the comprehensive Donanemab market report by a leading healthcare research firm, offering detailed insights, sales forecasts, and market analysis up to 2034.   [Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth … Continue reading

Spinal Cord Injury Market: Growth Momentum Across 7MM to 2034 – DelveInsight | Kringle Pharma, Neuroplast, Abbvie, Mitsubishi Tanabe Pharma, Lineage Cell Therapeutics, NervGen Pharma

The Key Spinal Cord Injury Companies in the market include – Athersys, Olatec Therapeutics, AlaMab therapeutics, ReNetX Bio, Histocell, Lineage Cell Therapeutics, AbbVie, Mitsubishi Tanabe Pharma, Pharmazz, Eusol Biotech, Kringle Pharma, NervGen Pharma, StemCyte, Inc., and others.   DelveInsight’s “Spinal … Continue reading

Follicular Lymphoma Clinical Trial Pipeline Accelerates as 45+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Follicular Lymphoma Pipeline Insight, 2025” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Follicular Lymphoma pipeline landscape. It covers the Follicular Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading